INDIA
Open source technology aiding Indian govt fight against Non-Communicable Diseases: Mallari Kulkarni, head, Digital LifeCare
The platform has been designed to meet the needs of health workers and doctors at primary, secondary and tertiary government facilities tasked with monitoring and following up on NCDs.
INDIA
Zika's silent spread calls for urgent need to strengthen virus surveillance: ICMR study
Calling for a continuous and enhanced surveillance for Zika virus, the study emphasises the need to develop a safe and effective vaccine which could be administered to pregnant women
TRENDS
Not planning to inoculate children below 12 years for COVID: NTAGI on US vaccinating children under five
Experts say COVID vaccines in children may not provide any additional benefit as most have already developed immunity as they have been exposed to the infection earlier.
TRENDS
Oncologists welcome FDA’s proposal to limit nicotine in cigarettes, but say India has a long road ahead
The oncologists feel that a huge political will is needed to establish nicotine level on tobacco products in India.
INDIA
All you need to know about drug regulatory framework in India and the process of drug approval
A pharmaceutical company in India must have DGCI approval for selling a new prescription drug. Different countries or blocs have separate regulatory agencies tasked with reviewing new drugs and medical devices before companies can sell them.
INDIA
Robotic surgery saves 15-year-old girl with single fused kidney and cyst
The patient, a 15-year-old girl, was born with development abnormalities that caused both her kidneys to fuse together on the left side and had an absent right kidney.
INDIA
CBI apprehends Joint Drug Controller in alleged Rs 4 lakh bribery case
The Associate Vice-President of Biocon Biologics has also been apprehended by CBI sleuths. However, Biocon Biologics, said they deny the allegations.
INDIA
CBI conducting searches at DCGI's Delhi office
The CBI is conducting searches in Delhi's Drug Controller Office in connection with alleged Rs 3 lakh bribery case.
TRENDS
One in eight persons suffers mental disorder globally: WHO report
"Business as usual for mental health simply will not do," says WHO
INDIA
Glenmark launches fixed-dose combination drug for asthma in India
The company said the drug will be available in three strengths with a fixed dose of Indacaterol and variable doses of Mometasone to be taken once daily.
INDIA
Online gaming pushing adolescents into aggressive behaviour: Experts
According to anecdotal evidence, there has been an increase of 30 to 40 percent in cases of aggressive behaviour by children addicted to online games.
TRENDS
Lupin Diagnostics launches first regional reference lab in Patna
By establishing a presence in Patna, after Assam and West Bengal, the Lupin Diagnostics aims to solidify its position in Eastern part of India.
TRENDS
Technology has huge role in India’s healthcare, we aim to fill existing gaps: Siraj Dhanani, CEO, InnAccel
Dhanani, the founder of Bengaluru based technology innovation company, feels India's potential of technological growth in healthcare sector completely untapped.
TRENDS
Air pollution India’s worst health threat, shortening life by 10 years in Delhi, says AQLI report
The report acknowledges that policy intervention in the form of the National Clean Air Programme would reduce particulate pollution by 20 percent to 30 percent by 2024, saying if India were to achieve and sustain the reduction, it would lead to remarkable health improvements
INDIA
How India’s routine immunisation bounced back from disruptions of COVID pandemic
According to the officials, in the last 2.5 years, the number of disease surveillance labs for measles and rubella have almost doubled; earlier there were 14 labs and now India has 27 labs.
INDIA
COVID case rise concerning but no reason to panic: NTAGI's NK Arora
Minimal deaths and hospitalisation show that the situation is under control, says Dr Arora, who leads the Working Group of the National Technical Advisory Group on Immunisation.
TRENDS
Why arrhythmia should not be ignored in younger people?
Cases of Sudden Arrhythmic Death Syndrome (SADS) is on the rise among those under 40 years of age, say leading cardiologists. India needs retrospective studies and government-led health initiatives that combine data from public and private hospitals for arrhythmia to provide accurate and timely treatment, say experts.
TRENDS
University of Glasgow opens Mazumdar-Shaw Advanced Research Centre
Mazumdar-Shaw Advanced Research Centre (ARC) aims to be the creative and collaborative heart of cross-disciplinary research at the University of Glasgow.
TRENDS
Delhi doctors develop a system to prevent post-heart attack fatalities
The model has been specially designed for predicting the chances of an Indian patient dying within 30 days of suffering a heart attack or surviving.
TRENDS
Stryker augments R&D in India with new global technology centre in Gurugram
The leading MedTech company said the technology centre in Gurugram will drive front-end innovation and research to build better healthcare services.
TRENDS
Can continuous glucose monitoring devices help you lose weight?
While such devices are typically used by type-I diabetes patients, it’s debatable whether they can help others lose weight.
TRENDS
ICMR releases guidelines for type-1 diabetes as cases rise among children
The council highlights steps to check the rising cases of type-1 diabetes among the Indian population.
TRENDS
Endless growth prospects for generics in India, Jan Aushadhi pharmacies aim to match growing demand: PMBI CEO Ravi Dadhich
Having seen an exponential rise in the number of outlets opening since 2015, the government, through Jan Aushadhi Kendras, aims to make the quality generic medicines available to every citizen
BUSINESS
AI and ML-based algorithms will provide impetus for Next-Gen diagnostics: Anand K, CEO, SRL Diagnostics
Testing for COVID-19 has seen a significant drop from being about 30 percent of SRL’s revenue in January to almost 7 percent in March. The CEO of SRL Diagnostics says that going forward about to 3-4 percent of their overall testing will be COVID-related, and the remaining, non-Covid
